InMed Pharmaceuticals (INM) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
InMed Pharmaceuticals announced the results of their 2024 Annual General Meeting, where shareholders approved the election of four directors and the appointment of CBIZ LLP as their auditors for the coming year. However, the election of Ms. Janet Grove was withheld, prompting her resignation offer, which is under consideration. The company is focused on developing drug candidates for diseases with high unmet needs.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
